Learning Center

Molecular Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care

Includes a Live Web Event on 10/08/2025 at 1:00 PM (EDT)

  • Register
    • General Attendee - Free!
    • Speaker - Free!
    • Prevent Cancer Foundation Staff - Free!

    Continue

In this session, delve into the cutting-edge science of Molecular Residual Disease (MRD) testing, a revolutionary approach to cancer detection and treatment guidance. Leaders in the field will discuss the history of MRD – its foundations in clinical medicine – and where the opportunities exist for further research and application. We’ll explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes.

Heather Parsons, M.D., MPH

Fred Hutchinson Cancer Center

Amir Jazaeri, M.D.

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center

Jeff Gregg, M.D.

Foresight Diagnostics

Lauren Leiman

BLOODPAC

Key:

Complete
Failed
Available
Locked
Webinar
10/08/2025 at 1:00 PM (EDT)  |  90 minutes
10/08/2025 at 1:00 PM (EDT)  |  90 minutes In this session, speakers will delve into the cutting-edge science of Minimal Residual Disease (MRD) testing, a revolutionary approach to cancer detection. We’ll explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes.
You must register to access.
Attestation of Attendance
Agree to terms to continue.
Agree to terms to continue.
You must register to access.
Program Evaluation for Minimal Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care
17 Questions
17 Questions This survey is required to earn continuing education credit hours. We encourage all viewers to complete this survey to tell us about your experience with this Prevent Cancer Dialogue program. Thank you!
You must register to access.
Post-Test for Minimal Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care
2 Questions  |  Unlimited attempts  |  3/2 points to pass
2 Questions  |  Unlimited attempts  |  3/2 points to pass Complete this post-test to earn continuing education credit hours. A score of 75% or better is required to earn credit.
You must register to access.
Additional Requirements for CE Reporting
2 Questions
2 Questions If requesting continuing education credits for this activity, please provide the required information below for reporting purposes, based upon the type of credit desired:
You must register to access.

This program is planning to offer continuing education credits for Certified Health Education Specialists (CHES), nurses, and advanced practice nurses. Please check back for more details soon!